• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LANSS 和 S-LANSS 问卷的波斯语版本:文化适应和验证研究。

Persian version of the LANSS and S-LANSS questionnaires: A study for cultural adaptation and validation.

机构信息

Department of Physical Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Department of Physical Therapy, Rofeideh Rehabilitation Hospital Clinical Research Development Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

出版信息

Appl Neuropsychol Adult. 2022 Sep-Oct;29(5):1095-1102. doi: 10.1080/23279095.2020.1848836. Epub 2020 Nov 24.

DOI:10.1080/23279095.2020.1848836
PMID:33232182
Abstract

The aim of this study was to culturally adapt and validate Leeds assessment of neuropathic symptoms and signs (LANSS) and self-report LANSS (S-LANSS) tools. Patients with chronic pain ( = 206) were categorized into neuropathic pain (NeP) ( = 101) or non-NeP ( = 105). After the translation process, both questionnaires and the Persian Douleur Neuropathique 4 (P-DN4) were administered to patients to assess the clinometric properties. The mean overall score of both tools was significantly higher in the NeP group ( < 0.01). Test-retest reliability analysis of the overall score of the Persian (P)-LANSS and PS-LANSS were 0.99 and 0.98, respectively. α-Cronbach value for P-LANSS and PS-LANSS were 0.64 and 0.61, respectively. Factor analysis of both questionnaires yielded two components explaining most of the observable variance. The P-LANSS was significantly correlated with PS-LANSS and P-DN4 (ρ = 0.92,  = 0.01, for both). PS-LANSS was also significantly correlated with P-DN4 ( = 0.79,  = 0.01). Both tools successfully diagnosed NeP patients at the cutoff point of ≥12 with 88.12% sensitivity and 76.19% specificity for P-LANSS and 83.17% sensitivity and 95.24% specificity for PS-LANSS. P-LANSS and PS-LANSS are reliable and valid tools to identify NeP component in chronic pain patients. PS-LANSS was found to be an acceptable alternative for P-LANSS.

摘要

本研究旨在对 Leeds 评估周围神经病理性症状和体征(LANSS)工具及其自评版(S-LANSS)进行文化调适和验证。将慢性疼痛患者( = 206)分为神经病理性疼痛(NeP)组( = 101)和非神经病理性疼痛(NeP)组( = 105)。在翻译过程之后,将两种问卷和 Persian Douleur Neuropathique 4(P-DN4)一起提供给患者,以评估临床计量学特性。两种工具的总体评分在 NeP 组中均显著更高( < 0.01)。波斯语版(P)-LANSS 和 PS-LANSS 总体评分的重测信度分析分别为 0.99 和 0.98。P-LANSS 和 PS-LANSS 的 α-Cronbach 值分别为 0.64 和 0.61。对两种问卷的因子分析得出了两个解释大部分可观测方差的成分。P-LANSS 与 PS-LANSS 和 P-DN4 显著相关(ρ = 0.92,  = 0.01,两者均为)。PS-LANSS 也与 P-DN4 显著相关( = 0.79,  = 0.01)。两种工具在 P-LANSS 的 cutoff 值≥12 时成功诊断出 NeP 患者,敏感性为 88.12%,特异性为 76.19%;PS-LANSS 的敏感性为 83.17%,特异性为 95.24%。P-LANSS 和 PS-LANSS 是可靠和有效的工具,可用于识别慢性疼痛患者的 NeP 成分。PS-LANSS 被发现是 P-LANSS 的可接受替代方法。

相似文献

1
Persian version of the LANSS and S-LANSS questionnaires: A study for cultural adaptation and validation.LANSS 和 S-LANSS 问卷的波斯语版本:文化适应和验证研究。
Appl Neuropsychol Adult. 2022 Sep-Oct;29(5):1095-1102. doi: 10.1080/23279095.2020.1848836. Epub 2020 Nov 24.
2
Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.将利兹神经病理性症状和体征评估量表(LANSS)及利兹神经病理性症状和体征自评量表(S-LANSS)问卷翻译成希腊语、进行文化调适及验证。
Pain Pract. 2016 Jun;16(5):552-64. doi: 10.1111/papr.12300. Epub 2015 Apr 16.
3
Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study.疼痛 DETECT 问卷土耳其语版用于评估神经性疼痛的有效性和可靠性研究。
Pain Med. 2013 Dec;14(12):1933-43. doi: 10.1111/pme.12222. Epub 2013 Aug 7.
4
Cross-cultural adaptation and validation of the Persian version of the painDETECT questionnaire.疼痛 DETECT 问卷波斯文版的跨文化调适与验证。
Curr Med Res Opin. 2021 Dec;37(12):2133-2139. doi: 10.1080/03007995.2021.1980778. Epub 2021 Sep 29.
5
Usefulness of the DN4, S-LANSS, and painDETECT screening questionnaires to detect the neuropathic pain components in people with acute whiplash-associated disorders: a cross-sectional study.DN4、S-LANSS 和 painDETECT 筛查问卷在检测急性挥鞭样损伤相关疾病患者神经病理性疼痛成分中的效用:一项横断面研究。
Pain Med. 2024 May 2;25(5):344-351. doi: 10.1093/pm/pnad165.
6
Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population.利兹神经病理性症状和体征评估量表(LANSS)在葡萄牙人群中的跨文化心理测量学评估。
Pain Pract. 2014 Sep;14(7):620-4. doi: 10.1111/papr.12118. Epub 2013 Dec 1.
7
Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.下背部相关腿痛患者中,神经病理性症状和体征的自我报告利兹评估与神经病理性疼痛4问题筛查工具之间的一致性和相关性。
J Manipulative Physiol Ther. 2012 Mar-Apr;35(3):196-202. doi: 10.1016/j.jmpt.2012.02.001. Epub 2012 Mar 6.
8
Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.西班牙语版自我管理的利兹神经病理性症状和体征评估量表(S-LANSS)疼痛量表的有效性和可靠性。
Neurologia (Engl Ed). 2018 Oct;33(8):505-514. doi: 10.1016/j.nrl.2016.10.009. Epub 2016 Dec 9.
9
Neuropathic Pain Questionnaire and Neuropathic Pain Questionnaire-Short Form: Translation, Reliability, and Validation Study of the Turkish Version.神经性疼痛问卷和神经性疼痛问卷简表:土耳其语版本的翻译、信度和效度研究
Turk Neurosurg. 2019;29(5):683-688. doi: 10.5137/1019-5149.JTN.25466-18.1.
10
Screening for neuropathic characteristics in failed back surgery syndromes: challenges for guiding treatment.腰椎手术失败综合征中神经病理性特征的筛查:指导治疗面临的挑战
Pain Med. 2015 Mar;16(3):520-30. doi: 10.1111/pme.12612. Epub 2014 Dec 19.

引用本文的文献

1
Possible Neuropathic Pain in Clinical Practice-Review on Selected Diagnostic Tools and Its Further Challenges.临床实践中可能存在的神经性疼痛——关于选定诊断工具及其进一步挑战的综述
Diagnostics (Basel). 2022 Dec 29;13(1):108. doi: 10.3390/diagnostics13010108.